Literature DB >> 17557132

Group A rotavirus genotypes in Germany during 2005/2006.

A Mas Marques1, S Diedrich, C Huth, E Schreier.   

Abstract

During the 2005/2006 winter season a total of 802 group A positive rotavirus specimens of patients from different regions throughout Germany were genotyped. Amplicons from a one-tube RT-PCR were typed by analysis of their (type-specific) size using type-specific primers, fluorescent consensus primers and a capillary sequencer for detection. While G1P[8] was predominant (45.8%), G9P[8] has emerged as the second most frequent genotype combination (37.7%). The distribution of genotypes was heterogeneous, regional frequencies regarding G1 and G9 were ranging from 15.0 to 89.3% and from 7.1 to 67.7%, respectively. Furthermore, a few human rotavirus G10P[6] and G10P[8] infections were observed.

Entities:  

Mesh:

Year:  2007        PMID: 17557132     DOI: 10.1007/s00705-007-0998-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Molecular characteristics of German G8P[4] rotavirus strain GER1H-09 suggest that a genotyping and subclassification update is required for G8.

Authors:  C Pietsch; L Petersen; L Patzer; U G Liebert
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

2.  Highly sensitive detection of the group A Rotavirus using Apolipoprotein H-coated ELISA plates compared to quantitative real-time PCR.

Authors:  Cornelia Adlhoch; Marco Kaiser; Marina Hoehne; Andreas Mas Marques; Ilias Stefas; Francisco Veas; Heinz Ellerbrok
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

3.  Differentiation between Wild-Type Group A Rotaviruses and Vaccine Strains in Cases of Suspected Horizontal Transmission and Adverse Events Following Vaccination.

Authors:  Sonja Jacobsen; Sandra Niendorf; Roswitha Lorenz; C-Thomas Bock; Andreas Mas Marques
Journal:  Viruses       Date:  2022-07-29       Impact factor: 5.818

4.  Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?

Authors:  Stefanie Knoll; Christoph Mair; Ursula Benter; Katja Vouk; Baudouin Standaert
Journal:  Health Econ Rev       Date:  2013-11-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.